US Pharma MarketingThe company said it is focused on using BCIs for neurological conditions now, with plans to expand the technology into noninvasive human-machine communication tools. Neurosoft Bioelectronics, a company developing a minimally invasive brain-computer interface, has closed a $7.5 million oversubscribed seed funding round, bringing its total funding to more than $20 million. Skybound Venture Capital led the round, with participation from IAG Capital Partners, Connecticut Innovations, PL Capital and others. Neurosoft Bioelectronics is a neurotechnology company developing a "highly-scalable" neural data platform. The company gathers data from its minimally invasive, implantable BCI systems to build a foundation model of the…
Neurosoft Bioelectronics, a company developing a minimally invasive brain-computer interface, has closed a $7.5 million oversubscribed seed funding round, bringing its total funding to more than $20 million.
Skybound Venture Capital led the round, with participation from IAG Capital Partners, Connecticut Innovations, PL Capital and others.
WHAT IT DOES
Source: MobiHealthNews